These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 25026415

  • 1. Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies.
    Jain D, Bajaj A, Athawale R, Shrikhande S, Goel PN, Nikam Y, Gude R, Patil S, Prashant Raut P.
    Drug Deliv; 2016; 23(3):999-1016. PubMed ID: 25026415
    [Abstract] [Full Text] [Related]

  • 2. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
    Guo W, Li A, Jia Z, Yuan Y, Dai H, Li H.
    Eur J Pharmacol; 2013 Oct 15; 718(1-3):41-7. PubMed ID: 24070814
    [Abstract] [Full Text] [Related]

  • 3. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y, Wei K, Zou F, Zhong S.
    Int J Pharm; 2012 Jul 01; 430(1-2):266-75. PubMed ID: 22486964
    [Abstract] [Full Text] [Related]

  • 4. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT, Joseph A, Shavi G, Rao JV, Udupa N.
    Drug Deliv; 2016 Sep 01; 23(7):2144-2153. PubMed ID: 25544603
    [Abstract] [Full Text] [Related]

  • 5. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation.
    Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK.
    J Microencapsul; 2011 Sep 01; 28(1):21-8. PubMed ID: 21171813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Investigations on pharmacokinetics and biodistribution of polymeric and solid lipid nanoparticulate systems of atypical antipsychotic drug: effect of material used and surface modification.
    Joseph E, Saha RN.
    Drug Dev Ind Pharm; 2017 Apr 01; 43(4):678-686. PubMed ID: 28044468
    [Abstract] [Full Text] [Related]

  • 15. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.
    Xing J, Zhang D, Tan T.
    Int J Biol Macromol; 2007 Jan 30; 40(2):153-8. PubMed ID: 16901536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH, Lu Q, Xie J, Fang C, Chen HZ.
    Biomaterials; 2010 Mar 30; 31(8):2278-92. PubMed ID: 20053444
    [Abstract] [Full Text] [Related]

  • 18. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC, Hsieh WY, Lee WF, Zeng DT.
    J Biomater Appl; 2013 Mar 30; 27(7):909-22. PubMed ID: 22207601
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.